Psychedelics
Joël Brierre Calls To Those Seeking Transformation – Podcast Episode #24
On the season three premiere of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Joël Brierre. Joel Brierre is the Founder and CEO of…
On the season three premiere of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Joël Brierre.
Joel Brierre is the Founder and CEO of the psychedelic wellness companies Kaivalya Kollectiv and Tandava Retreats, as well as co-founder of the 5-MeO-DMT education and training platform, F.I.V.E.. Joel has been a leader in the modern psychedelic movement, specifically in the realm of 5-MeO-DMT and the Bufo Alvarius toad, and has spent years helping to create safe and effective protocols around this molecule. With a passion for preparation and integration protocols, Joel and his team are involved in everything from clinical research and trainings to experiential retreats in Mexico and Jamaica.
Listen To All Episodes on YouTube
All season two episodes are now available on YouTube. Check out the Psychedelic Invest YouTube channel to listen to the entire season without a subscription.
More To Come for Season Three
We have a great season of another ten full episodes planned out for your enjoyment.
If you just found out about the podcast, we encourage you to check out the Psychedelic Invest Podcast page or subscribe to the show on your favorite audio platform to binge and catch up.
The Transcription is Coming Soon
-
Law & Regulation1 week ago
Relmada Therapeutics trims losses, slashes research costs
-
Psychedelics1 week ago
Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
-
Psychedelics1 week ago
Numinus Wellness Submits Clinical Trial Application
-
Psychedelics1 week ago
Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
-
Psychedelics1 week ago
MindBio Therapeutics Corp. Begins Phase 2B Take-Home Microdosing Clinical Trial in Patients with Major Depressive Disorder
-
Psilocybin7 days ago
Indigenous Psilocybin Practices Around the World
-
Law & Regulation1 week ago
Gilgamesh secures $14M for ibogaine-like drug
-
Psychedelics1 week ago
Gilgamesh Receives Grant To Combat Opioid Dependency